BiotechTube
Home/Cingulate Therapeutics/C. Thomas Amick
CT

C. Thomas Amick

Co-Founder, President & Chief Operating Officer

Cingulate Therapeutics

Therapeutic Areas

Central Nervous System (CNS)Psychiatry

Cingulate Therapeutics Pipeline

DrugIndicationPhase
CTx-1301Attention-Deficit/Hyperactivity Disorder (ADHD)Phase 3
CTx-1302Attention-Deficit/Hyperactivity Disorder (ADHD)Phase 3
CTx-2103Generalized Anxiety Disorder (GAD)Phase 2

Leadership Team at Cingulate Therapeutics

SJ
Shane J. Schaffer
Chairman & Chief Executive Officer
MB
Matthew Brams
Chief Medical Officer
LP
Louise P. Short
Chief Financial Officer
JS
Jeffrey S. Ervin
Chief Commercial Officer
View full Cingulate Therapeutics profile